Registration Strip Icon for charts Registrati per grafici in tempo reale, strumenti di analisi e prezzi.

Viatris Inc

VTRS
10,90
0,10 (0,93%)
15 Feb 2025 - Chiuso
Dati in Delay di 15 minuti
Borsa: NASDAQ
Tipo: Azione
Valuta: USD

Ultime notizie

Data Ora Fonte Titolo
03/2/202522:30PRNUSViatris to Report Fourth Quarter and Full Year 2024..
07/1/202512:59PRNUSViatris to Present at the 43rd Annual J.P. Morgan Healthcare..
04/1/202500:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
18/12/202412:59PRNUSViatris Announces Publication of Phase 2b CARE Study Data..
06/12/202423:20EDGAR2Form 8-K - Current report
07/11/202413:58EDGAR2Form 8-K - Current report
07/11/202412:59PRNUSViatris Reports Third Quarter Financial Results for 2024
05/11/202412:59PRNUSViatris Announces Third Quarter 2024 Dividend
29/10/202417:00PRNUSViatris Named to Forbes' World's Top Companies for Women..
29/10/202414:00PRNUSViatris to Participate in the UBS Global Healthcare..
25/10/202422:40EDGAR2Form ARS - Annual Report to Security Holders
25/10/202422:37EDGAR2Form DEFA14A - Additional definitive proxy soliciting..
25/10/202422:35EDGAR2Form DEF 14A - Other definitive proxy statements
16/10/202422:35GLOBELexicon Announces Exclusive Licensing Agreement With Viatris..
16/10/202422:34PRNUSViatris Announces Exclusive Licensing Agreement with Lexicon..
09/10/202412:59PRNUSViatris Announces Positive Top-line Results from Phase 3..
08/10/202417:00PRNUSViatris Named to Forbes' Annual List of the World's Best..
30/9/202412:59PRNCAViatris launches (Pr)Viagra® ODF in Canada: a new oral..
27/9/202422:00EDGAR2Form 8-K - Current report
18/9/202417:30PRNUSViatris Announces the Pricing Terms of Maximum Tender Offer
18/9/202402:45PRNUSViatris Announces Early Tender Results and Increase of..
16/9/202422:30PRNUSViatris to Report Third Quarter 2024 Financial Results on..
11/9/202401:00PRNUSViatris Announces Expiration and Results of Any and All Cash..
10/9/202417:40PRNUSViatris Announces the Pricing Terms of Pending Any and All..
04/9/202413:46EDGAR2Form 8-K - Current report
04/9/202409:30PRNUSViatris Announces Cash Tender Offers for Certain Outstanding..
23/8/202412:59PRNUSViatris Presents Late Breaking Abstract on Cenerimod at the..
08/8/202414:03EDGAR2Form 8-K - Current report
08/8/202412:59PRNUSViatris Reports Second Quarter Financial Results for 2024
06/8/202412:59PRNUSViatris Announces Second Quarter 2024 Dividend
06/8/202411:44IHMARKETNEWSGoogle Faces Antitrust Ruling; SunPower Files for Bankruptcy..
03/7/202414:30PRNUSViatris Brings to Completion All Previously Announced..
02/7/202413:30PRNUSU.S. Department of Justice Informs Viatris That It No Longer..
25/6/202417:00PRNUSViatris Named to TIME's World's Most Sustainable Companies..
07/6/202412:59PRNUSViatris to Report Second Quarter 2024 Financial Results on..
04/6/202412:59PRNUSViatris to Participate in the Goldman Sachs 45th Annual..
03/6/202413:16EDGAR2Form 8-K - Current report
03/6/202412:59PRNUSViatris Appoints Rogerio Vivaldi Coelho, M.D., to Board of..
31/5/202412:59PRNUSViatris to Participate in the Jeffries Global Healthcare..
29/5/202400:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
28/5/202422:04EDGAR2Form 144 - Report of proposed sale of securities
21/5/202412:59PRNUSViatris Publishes 2023 Sustainability Report: Building..
09/5/202413:47IHMARKETNEWSU.S. Index Futures Dip, Bank of England Holds Interest Rates..
09/5/202413:44EDGAR2Form 8-K - Current report
09/5/202412:59PRNUSViatris Reports Strong First Quarter 2024 Financial Results..
02/5/202423:00PRNUSViatris to Participate in the BofA Securities 2024 Health..
01/5/202412:59PRNUSViatris Expands its Wellbeing Program with the Launch of..
16/4/202422:30PRNUSViatris to Report First Quarter 2024 Financial Results on..
15/4/202414:00PRNUSViatris Appoints Corinne Le Goff as Chief Commercial Officer
15/4/202412:59PRNCAViatris Announces Launch of First Bioequivalent Generic..
Apertura: 10,88 Min: 10,78 Max: 11,02
Chiusura: 10,80

La tua Cronologia

Delayed Upgrade Clock

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network